Subscribe to RSS
DOI: 10.1055/s-2001-18536
Leitlinien der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten zur Behandlung der Dyspepsie
Guidelines of the German Society of Metabolic and Digestive Diseases for the therapy of dyspesiaPublication History
Publication Date:
21 November 2001 (online)

Vorbemerkungen
Auf den Oberbauch bezogene Symptome sind in unserer Bevölkerung sehr verbreitet und häufig Anlass für ärztliche Konsultationen. Mit dem Ziel, die Grundlagen für eine rational begründete Diagnostik und Therapie dieses Krankheitskomplexes zu erarbeiten, sind in den letzten Jahren verschiedene internationale Expertengremien aktiv geworden [1 4].
Im Mai 1999 fand in Magdeburg eine Leitlinen-Konferenz der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten statt, die rational begründete Empfehlungen für die Diagnostik und Therapie bei Dyspepsie entwickeln sollte. Neben Gastroenterologen waren in die Konferenz auch Allgemeinmediziner, Pädiater sowie Psychosomatiker und Vertreter der Kostenträger eingebunden.
In der Vorbereitungsphase der Leitlinienkonferenz wurden folgende 3 Themenkomplexe festgelegt und die eingeladenen Teilnehmer entsprechend den 3 Arbeitsgruppen zugeordnet:
Grundlagen der Dyspepsie: Definition, Epidemiologie, Pathophysiologie, diagnostische Verfahren klinisches Vorgehen bei Dyspepsie (klinische Anwendung der Diagnostik, Therapie) klinische Evaluierung und Gesundheitsökonomie
Mittels Fragebogen wurden Bewertungen und Kommentare zu vorbereiteten Aussagen von den Mitgliedern der 3 Arbeitsgruppen eingeholt und allen Teilnehmern der Leitlinienkonferenz zur Verfügung gestellt.
Die Bewertung der Aussagen und Empfehlungen erfolgte nach dem Evidenzgrad (s. Tab. [1]) basierend auf den Richtlinien von S. H. Woolf [5].
In der Leitlinienkonferenz selbst wurden zunächst in den 3 Arbeitsgruppen die Aussagen und Empfehlungen ausgearbeitet, durch Literatur belegt und erneut nach dem Evidenzgrad bewertet. In einer abschließenden Konferenz stimmten alle Teilnehmer über die Aussagen und Empfehlungen ab, gegebenfalls wurden Kommentare ergänzt.
Tab. 1 Stärke der Evidenz I-1 Evidenz durch Metaanalysen randomisierter kontrollierter Studien I-2 Evidenz durch mindestens eine geeignet geplante randomisierte kontrollierte Studie II-1 Evidenz durch gut geplante kontrollierte Studien ohne Randomisierung II-2 Evidenz durch gut geplante Kohorten- oder Fallkontrollstudien, vorzugsweise von mehr als einem Studienzentrum oder einer Forschergruppe II-3 Evidenz durch Vergleiche von Zeitabschnitten oder Zentren mit oder ohne Intervention, dramatische Veränderungen in Experimenten ohne Kontrollgruppe können auch in diese Kategorie eingestuft werden III Evidenz durch Meinungsbildner, basierend auf klinischen Erfahrungen, Beobachtungsstudien oder Berichten von Expertenkommissionen
Literatur
- 1
Talley N J, Silverstein M D, Agréus L. et al .
Evaluation of
dyspepsia.
Gastroenterology.
1998;
114
582-595
MissingFormLabel
- 2
Talley N J, Axon A, Bytzer P. et al .
Management of uninvestigated and functional dyspepsia: a
working party report for the world congresses of
gastroenterology.
Aliment Pharmacol
Ther.
1999;
13
1135-1148
MissingFormLabel
- 3
Drossman D A, Thompson W G, Talley N J. et al .
Identification of sub-groups of functional gastrointestinal
disorders.
Gastroenterol
Int.
1990;
3
159-172
MissingFormLabel
- 4 Drossman D A, Richter J E, Talley N J. et al .The functional gastrointestinal disorders. Boston,
New York, Toronto, London; Little, Brown and
Company 1994
MissingFormLabel
- 5
Woolf S H.
Practice guidelines, a new reality in
Medicine.
Arch Intern
Med.
1992;
152
946-952
MissingFormLabel
- 6
Hollnagel H, Norrelund N, Larsen S.
Marve-tarmsymptomer blandt 40-arige i Glostrup: En
epidemiologisk undersogelse.
Ugeskr
Laeger.
1982;
144
267-273
MissingFormLabel
- 7
Johnsen R, Straume B, Forde O H.
Peptic ulcer and non-ulcer dyspepsia - a disease and a
disorder.
Scand J Prim Health
Care.
1988;
6
239-243
MissingFormLabel
- 8
Schlemper R J, Van
der
Werf S DJ, Vandenbroucke J P, Biemond I, Lamers C BHW.
Nonulcer dyspepsia in a Dutch working population and
Helicobacter pylori: Ulcer history as an explanation of an apparent
association.
Arch Intern
Med.
1995;
155
82-87
MissingFormLabel
- 9
Jones R, Lydeard S.
Prevalence of symptoms of dyspepsia in the
community.
BMJ.
1989;
298
30-32
MissingFormLabel
- 10
Talley N J, Weaver A L, Zinsmeister A R, Melton L J
III.
Onset and disappearance of gastrointestinal symptoms and
functional gastrointestinal disorders.
Am J
Epidemiol.
1992;
136
165-177
MissingFormLabel
- 11
Agreus L, Svärdsudd K, Nyren O, Tibblin G.
Irritable bowel syndrome and dyspepsia in the general
population: Overlap and lack of stability over
time.
Gastroenterology.
1995;
109
671-680
MissingFormLabel
- 12
Bytzer P, Hansen J M, Schaffalitzky
de Muckadell O B.
Empirical H2-blocker therapy or prompt endoscopy in
management of
dyspepsia.
Lancet.
1994;
343
811-116
MissingFormLabel
- 13
Silverstein M D, Petterson T, Talley N J.
Initial endoscopy or empirical therapy with or without
testing for Helicobacter pylori for dyspepsia: A decision
analysis.
Gastroenterology.
1996;
110
72-83
MissingFormLabel
- 14
Armstrong D, Arnold R, Classen M. et al .
RUDER - A prospective, two year multicenter study of
risk factors for duodenal ulcer relapse during maintenance therapy with
ranitidine.
Dig Dis
Sci.
1994;
39
1425-1433
MissingFormLabel
- 15
Talley N J, McNeil D, Piper D W.
Environmental factors and chronic unexplained dyspepsia.
Association with acetaminophen but not other analgesics, alcohol, coffee, tea,
or smoking.
Dig Dis
Sci.
1988;
33
641-648
MissingFormLabel
- 16
Elta G H, Behler E M, Colturi T.
Comparison of coffee intake and coffee-induced symptoms in
patients with duodenal ulcers, non-ulcer dyspepsia and normal
controls.
Am J
Gastroenterol.
1990;
85
1339-1342
MissingFormLabel
- 17
Talley N J, Weaver A L, Tesmer D L, Zinsmeister A R.
Lack of discriminant value of dyspepsia subgroups in patients
referred for upper
endoscopy.
Gastroenterology.
1993;
105
1378-1386
MissingFormLabel
- 18
Carlsson R, Dent J, Glise H. et al .
Evaluation of a questionnaire for the diagnosis of
symptomatic gastroesophageal reflux disease
(GERD).
Gastroenterology.
1996;
110
A76
MissingFormLabel
- 19
Boyd E JS.
The prevalence of esophagitis in patients with duodenal ulcer
or ulcer-like dyspepsia.
Am J
Gastroenterol.
1996;
91
1539-1543
MissingFormLabel
- 20
Talley N J, Stanghellini V, Heading R C. et al .
Functional gastroduodenal
disorders.
Gut.
1999;
45 Suppl.
II
37-42
MissingFormLabel
- 21
Rasquin-Weber A, Hyman P E, Cucchiara S. et al .
Childhood functional gastrointestinal
disorders.
Gut.
1999;
45
60-68
(Suppl
II)
MissingFormLabel
- 22
Klauser A G, Schindlbeck N E, Müller-Lissner S A.
Symptoms in gastro-oesophageal reflux
disease.
Lancet.
1990;
1
205-208
MissingFormLabel
- 23
Small P K, London M A, Waldron B, Smith D, Campbell F C.
Importance of reflux symptoms in functional
dyspepsia.
Gut.
1995;
36
189-192
MissingFormLabel
- 24
Talley N J, Colin-Jones D, Koch K L. et al .
Functional dyspepsia: A classification with guidelines for
diagnosis and management.
Gastroenterol
Int.
1991;
4
145-160
MissingFormLabel
- 25
Hotz J, Enck P, Goebell H. et al .
Konsensusbericht: Reizdarmsyndrom- Definition,
Diagnosesicherung, Pathophysiologie und Therapiemöglichkeiten. Konsensus
der Deutschen Gesellschaft und Verdauungs- und
Stoffwechselkrankheiten.
Z
Gastroenterol.
1999;
37
685-700
MissingFormLabel
- 26
Holtmann G, Goebell H, Talley N J.
Functional dyspepsia and irritable bowel syndrome: is there a
common pathophysiological basis?.
Am J
Gastroenterol.
1997;
92
954-959
MissingFormLabel
- 27
Talley N J, Holtmann G, Zinsmeister A R, Jones M.
Gastrointestinal symptoms cluster into distinct upper and
lower groupings consistent with the Rome classification: a three country
population-based
study.
Gastroenterology.
1997;
112
A835
MissingFormLabel
- 28
Talley N J, Zinsmeister A R, Schleck C D, Melton L JI.
Dyspepsia and dyspepsia subgroups: A population-based
study.
Gastroenterology.
1992;
102
1259-1268
MissingFormLabel
- 29
Holtmann G, Goebell H, Talley N J.
Dyspepsia in consulters and non-consulters: prevalence,
health-care seeking behaviour and risk factors.
Eur J Gastroenterol
Hepatol.
1994;
6
917-924
MissingFormLabel
- 30
Schlemper R, Van der
Werf S DJ, Vandenbroucke J P, Biemond I, Lamers C BHW.
Peptic ulcer, non-ulcer dyspepsia and irritable bowel
syndrome in The Netherlands and Japan.
Scand J Gastroenterol
Suppl.
1993;
200
33-41
MissingFormLabel
- 31
Doll R, Jones F A, Buckatzsch M M.
Occupational factors in the aetiology of gastric and duodenal
ulcers with an estimate of their incidence in the general
population.
Med Res Council Spec Rep
Ser.
1951;
276
1-9
MissingFormLabel
- 32
Weir R D, Backett E M.
Studies of the epidemiology of peptic ulcer in a rural
community: Prevalence and natural history of dyspepsia and peptic
ulcer.
Gut.
1968;
9
75-83
MissingFormLabel
- 33 Banke L. Ulcumygdommers epidemiologi
Kobenhavn. F.A.D.L.’s
Forlag 1975
MissingFormLabel
- 34
Thompson W G, Heaton K W.
Functional bowel disorders in apparently healthy
people.
Gastroenterology.
1980;
79
283-288
MissingFormLabel
- 35
Shirlow M J, Mathers C D.
A study of caffeine consumption and symptoms: Indigestion,
palpitations, tremor, headache, and insomnia.
Int J
Epidemiol.
1985;
14
239-248
MissingFormLabel
- 36
Tibblin G.
Introduction to the epidemiology of
dyspepsia.
Scand J
Gastroenterol.
1985;
109
29-33
(Suppl)
MissingFormLabel
- 37
Jones R H, Lydeard S E, Hobbs F DR. et al .
Dyspepsia in England
andScotland.
Gut.
1990;
31
401-405
MissingFormLabel
- 38
Harrison J D, Morris D L.
Dyspepsia in coalminers and the general population: A
comparative study.
Br J Ind
Med.
1989;
46
428-429
MissingFormLabel
- 39
Bernersen B, Johnsen R, Straume B. et al .
Towards a true prevalence of peptic ulcer: the Sorreisa
gastrointestinal disorder
study.
Gut.
1990;
31
989-992
MissingFormLabel
- 40
Drossman D A, Li Z, Andruzzi E. et al .
U.S. Householder survey of functional gastrointestinal
disorders. Prevalence, sociodemography, and health impact.
Dig Dis
Sci.
1993;
38
1569-1580
MissingFormLabel
- 41
Talley N J.
Gastroduodenal motility. Curr
Opin.
Gastroenterol.
1994;
618-622
MissingFormLabel
- 42
Persico M, Suozzo R, De
Seta M. et al .
Non-ulcer dyspepsia and Helicobacter pylori in type 2
diabetic patients: Association with autonomic neuropathy.
Diabetes
Res Clin
Pract.
1996;
31
87-92
MissingFormLabel
- 43
Mearin F, Malagelada J R.
Gastroparesis and dyspepsia in patients with diabetes
mellitus.
Eur J Gastroenterol
Hepatol.
1995;
7
717-723
MissingFormLabel
- 44
Martin T R, Vennes J A, Silvis S E, Ansel H J.
A comparison of upper gastrointestinal endoscopy and
radiography.
J Clin
Gastroenterol.
1980;
2
21-25
MissingFormLabel
- 45
Shaw P C, van
Romunde L K, Griffioen G. et al .
Detection of gastric erosions: Comparison of biphasic
radiography with fiberoptic
endoscopy.
Radiology.
1991;
178
63-66
MissingFormLabel
- 46
Shaw P C, van
Romunde L K, Griffioen G. et al .
Peptic ulcer and gastric carcinoma: Diagnosis with biphasic
radiography compared with fiberoptic
endoscopy.
Radiology.
1987;
163
39-42
MissingFormLabel
- 47
Dooley C P, Larson A W, Stace N H. et al .
Double-contrast barium meal and upper gastrointestinal
endoscopy. A comparative study.
Ann Intern
Med.
1984;
101
538-545
MissingFormLabel
- 48
Longstreth G F.
Long-term costs after gastroenterology consultation with
endoscopy versus radiography in dyspepsia.
Gastrointest
Endosc.
1992;
38
23-26
MissingFormLabel
- 49
Hart R, Classen M.
Complications of diagnostic gastrointestinal
endoscopy.
Endoscopy.
1990;
22
229-233
MissingFormLabel
- 50
Daneshmend T K, Bell G D, Logan R F.
Sedation for upper gastrointestinal endoscopy: Results of a
nationwide
survey.
Gut.
1991;
32
12-15
MissingFormLabel
- 51
Frazier A L, Colditz G A, Fuchs C S, Kuntz K M.
Cost-effectiveness of screening for colorectal cancer in the
general
population.
JAMA.
2000;
284
1954-1961
MissingFormLabel
- 52
Komuta K, Furui J, Haraguchi M, Kanematsu T.
The detection of colorectal cancer at an asymptomatic stage
by screening is
useful.
Hepatogastroenterology.
2000;
47
1011-1114
MissingFormLabel
- 53
Lieberman D A.
Cost-effectiveness model for colon cancer
screening.
Gastroenterology.
1995;
109
1781-1790
MissingFormLabel
- 54
Sonnenberg A, Delco F, Inadomi J M.
Cost-Effectiveness of Colonoscopy in Screening for Colorectal
Cancer.
Ann Intern
Med.
2000;
133
573-584
MissingFormLabel
- 55
Berstad A, Hausken T, Gilja O H, Nesland A, Odegaard S.
Imaging studies in dyspepsia.
Eur J Surg
Suppl.
1998;
42-49
MissingFormLabel
- 56
Wilhelmsen I, Haug T T, Ursin H, Berstad A.
Discriminant analysis of factors distinguishing patients with
functional dyspepsia from patients with duodenal ulcer. Significance of
somatization.
Dig Dis
Sci.
1995;
40
1105-1111
MissingFormLabel
- 57
Talley N J, Evans J M, Fleming K C, Harmsen W S, Zinsmeister A R, Melton
III L J.
Nonsteroidal antiinflammatory drugs and dyspepsia in the
elderly.
Dig Dis
Sci.
1995;
40
1345-1350
MissingFormLabel
- 58
Hallas J, Bytzer P.
Screening for drug related dyspepsia: an analysis of
prescription symmetry.
Eur J Gastroenterol
Hepatol.
1998;
10
27-32
MissingFormLabel
- 59
Moayyedi P, Forman D, Braunholtz D. et al .
The proportion of upper gastrointestinal symptoms in the
community associated with Helicobacter pylori, lifestyle factors, and
nonsteroidal anti-inflammatory drugs. Leeds HELP Study Group.
Am J
Gastroenterol.
2000;
95(6)
1448-1455
MissingFormLabel
- 60
Crean G P, Holden R J, Knill-Jones R P. et al .
A database on
dyspepsia.
Gut.
1994;
35
191-202
MissingFormLabel
- 61
Gillen D, McColl K E.
Does concern about missing malignancy justify endoscopy in
uncomplicated dyspepsia in patients aged less than 55?.
Am J
Gastroenterol.
1999;
94
75-79
MissingFormLabel
- 62
European Helicobacter Pylori Study Group .
Current European concepts in the management of Helicobacter
pylori infection. The Maastricht Consensus
Report.
GUT.
1997;
41
8-13
MissingFormLabel
- 63
Small P K, Loudon M A, Waldron B, Smith D, Campbell F C.
Importance of reflux symptoms in functional
dyspepsia.
Gut.
1995;
36
189-192
MissingFormLabel
- 64
Sonnenberg A, Delco F, El
Serag H B.
Empirical therapy versus diagnostic tests in gastroesophageal
reflux disease: a medical decision analysis.
Dig Dis
Sci.
1998;
43
1001-1008
MissingFormLabel
- 65
Ofman J J, Etchason J, Fullerton S, Kahn K L, Soll A H.
Management strategies for Helicobacter pylori-seropositive
patients with dyspepsia: clinical and economic consequences.
Ann
Intern
Med.
1997;
126
280-291
MissingFormLabel
- 66
Sonnenberg A.
Cost-benefit analysis of testing for Helicobacter pylori in
dyspeptic subjects.
Am J
Gastroenterol.
1996;
91
1773-1777
MissingFormLabel
- 67
Olson A D, Fendrick A M, Deutsch D. et al .
Evaluation of initial noninvasive therapy in pediatric
patients presenting with suspected ulcer disease.
Gastrointest
Endosc.
1996;
44
554-561
MissingFormLabel
- 68
McColl K E, El-Nujumi A, Murray L. et al .
The Helicobacter pylori breath test: A surrogate marker for
peptic ulcer disease in dyspeptic
patients.
Gut.
1997;
40
302-306
MissingFormLabel
- 69
Lassen A T, Pedersen
F M, Bytzer
P, Schaffalitzky De
Muckadell O B.
Helicobacter pylori test-and-eradicate versus prompt
endoscopy for management of dyspeptic patients: A randomised
trial.
Lancet.
2000;
356
455-460
MissingFormLabel
- 70
Holtmann G, Talley N J.
Functional dyspepsia. Current treatment
recommendations.
Drugs.
1993;
45
918-930
MissingFormLabel
- 71
Meineche-Schmidt V, Christensen E.
Classification of dyspepsia. Identification of independent
symptom components in 7270 consecutive, unselected dyspepsia patients from
general practice.
Scand J
Gastroenterol.
1998;
33
1262-1272
MissingFormLabel
- 72
Patel P, Khulusi S, Mendall M A. et al .
Prospective screening of dyspeptic patients by Helicobacter
pylori
serology.
Lancet.
1995;
346
1315-1318
MissingFormLabel
- 73
Jones R, Tait C, Sladen G, Weston-Baker J.
A trial of a test-and-treat strategy for Helicobacter pylori
positive dyspeptic patients in general practice.
Int J Clin
Pract.
1999;
53
413-416
MissingFormLabel
- 74
Wilcox M H, Dent T H, Hunter J O. et al .
Accuracy of serology for the diagnosis of Helicobacter pylori
infection - a comparison of eight kits.
J Clin
Pathol.
1996;
49
373-376
MissingFormLabel
- 75
Leodolter A, Dominguez-Munoz J E, von
Arnim U. et al .
Validity of a modified 13C-urea breath test for pre- and
posttreatment diagnosis of Helicobacter pylori infection in the routine
clinical setting.
Am J
Gastroenterol.
1999;
94
2100-2104
MissingFormLabel
- 76
Vaira D, Malfertheiner P, Megraud F. et al .
Diagnosis of Helicobacter pylori infection with a new
non-invasive antigen-based assay. HpSA European study
group.
Lancet.
1999;
354
30-33
MissingFormLabel
- 77
Thijs J C, van
Zwet A A, Thijs W J. et al .
Diagnostic tests for Helicobacter pylori: A prospective
evaluation of their accuracy, without selecting a single test as the gold
standard.
Am J
Gastroenterol.
1996;
91
2125-2129
MissingFormLabel
- 78
Klauser A G, Voderholzer W A, Knesewitsch P A, Schindlbeck N E, Muller-Lissner S A.
What is behind dyspepsia?.
Dig Dis
Sci.
1993;
38
147-154
MissingFormLabel
- 79
Caspary W F, Arnold R, Bayerdorffer E. et al .
Diagnose und Therapie der Helicobacter pylori Infektion.
Leitlinien der Deutschen Gesellschaft für Verdauungs- und
Stoffwechselkrankheiten DGVS.
Z
Gastroenterol.
1996;
34
392-401
MissingFormLabel
- 80
Halter F, Miazza B, Brignoli R.
Cisapride or cimetidine in the treatment of functional
dyspepsia. Results of a double-blind, randomized, Swiss multicentre
study.
Scand J
Gastroenterol.
1994;
29
618-623
MissingFormLabel
- 81
Gilvarry J, Buckley M J, Beattie S, Hamilton H, O’Morain C A.
Eradication of Helicobacter pylori affects symptoms in
non-ulcer dyspepsia.
Scand J
Gastroenterol.
1997;
32
535-540
MissingFormLabel
- 82
Talley N J, Weaver A L, Zinsmeister A R.
Smoking, alcohol, and nonsteroidal anti-inflammatory drugs in
outpatients with functional dyspepsia and among dyspepsia
subgroups.
Am J
Gastroenterol.
1994;
89
524-528
MissingFormLabel
- 83
Mullan A, Kavanagh P, O’Mahony P. et al .
Food and nutrient intakes and eating patterns in functional
and organic dyspepsia.
Eur J Clin
Nutr.
1994;
48
97-105
MissingFormLabel
- 84
Jones R H, Baxter G.
Lansoprazole 30 mg daily versus ranitidine
150 mg b. d. in the treatment of acid-related dyspepsia in
general practice.
Aliment Pharmacol
Ther.
1997;
11
541-546
MissingFormLabel
- 85
Blum A L, Arnold R, Stolte M, Fischer M, Koelz H R.
Short course acid suppressive treatment for patients with
functional dyspepsia: Results depend on Helicobacter pylori
status.
Gut.
2000;
47
473-480
MissingFormLabel
- 86
Talley N J, Meineche-Schmidt V, Pare P. et al .
Efficacy of omeprazole in functional dyspepsia: Double-blind,
randomized, placebo-controlled trials (the Bond and Opera
studies).
Aliment Pharmacol
Ther.
1998;
12
1055-1065
MissingFormLabel
- 87
Soo S, Moayyedi P, Deeks J. et al .
Pharmacological interventions for non-ulcer
dyspepsia.
Cochrane Database Syst
Rev.
2000;
2
CD001960
MissingFormLabel
- 88
Veldhuyzen van Zanten S J.
Treatment of functional dyspepsia.
Baillieres Clin
Gastroenterol.
1998;
12
573-586
MissingFormLabel
- 89
Finney J S, Kinnersley N, Hughes M, O’Bryan-Tear C G, Lothian J.
Meta-analysis of antisecretory and gastrokinetic compounds in
functional dyspepsia.
J Clin
Gastroenterol.
1998;
26
312-320
MissingFormLabel
- 90
Veldhuyzen van
Zanten S J, Cleary C, Talley N J. et al .
Drug treatment of functional dyspepsia: A systematic analysis
of trial methodology with recommendations for design of future
trials.
Am J
Gastroenterol.
1996;
91
660-673
MissingFormLabel
- 91
Dent J, Brun J, Fendrick M. et al .
An evidence-based appraisal of reflux disease management
- the Genval Workshop
Report.
Gut.
1999;
44 Suppl
2
1-16
MissingFormLabel
- 92
Talley N J.
A critique of therapeutic trials in Helicobacter
pylori-positive functional
dyspepsia.
Gastroenterology.
1994;
106
1174-1183
MissingFormLabel
- 93
Moayyedi P, Soo S, Deeks J. et al .
Systematic review and economic evaluation of Helicobacter
pylori eradication treatment for non-ulcer
dyspepsia.
BMJ.
2000;
321
659-664
MissingFormLabel
- 94
Drumm B, Koletzko S, Oderda G.
Helicobacter pylori infection in children: A consensus
statement. European Paediatric Task Force on Helicobacter pylori.
J
Pediatr Gastroenterol
Nutr.
2000;
30
207-213
MissingFormLabel
- 95
Sipponen P, Varis K, Fraki O. et al .
Cumulative 10-year risk of symptomatic duodenal and gastric
ulcer in patients with or without chronic gastritis. A clinical follow-up study
of 454 outpatients.
Scand J
Gastroenterol.
1990;
25
966-973
MissingFormLabel
- 96
Blum A L, Talley N J, O’Morain C. et al .
Lack of effect of treating Helicobacter pylori infection in
patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and
Amoxicillin Effect One Year after Treatment (OCAY) Study Group.
N
Engl J
Med.
1998;
339
1875-1881
MissingFormLabel
- 97
McColl K, Murray L, El-Omar E. et al .
Symptomatic benefit from eradicating Helicobacter pylori
infection in patients with nonulcer dyspepsia.
N Engl J
Med.
1998;
339
1869-1874
MissingFormLabel
- 98
Holtmann G, Madisch A, Hotz J.
A double blind randomized, placebo-controlled trial on the
effects of a herbal preparation in patients with functional
dyspepsia.
Gastroenterology.
1999;
116
A65
MissingFormLabel
- 99
Mertz H, Fass R, Kodner A. et al .
Effect of amitriptyline on symptoms, sleep, and visceral
perception in patients with functional dyspepsia.
Am J
Gastroenterol.
1998;
93
160-165
MissingFormLabel
- 100
Corazza G R, Biagi F, Albano O. et al .
Levosulpiride in functional dyspepsia: A multicentric,
double-blind, controlled trial.
Ital J
Gastroenterol.
1996;
28
317-323
MissingFormLabel
- 101
Macarri G, Biasi L, Brunelli E, Marucci L, Svegliati
Baroni G.
L-sulpiride versus metoclopramide in functional dyspepsia: A
randomized double-blind study.
Minerva
Med.
1992;
83
295-298
MissingFormLabel
- 102
Holtmann G, Gschossmann J, Karaus M. et al .
Randomised double-blind comparison of simethicone with
cisapride in functional dyspepsia.
Aliment Pharmacol
Ther.
1999;
13
1459-1465
MissingFormLabel
- 103
Olden K W.
Are psychosocial factors of aetiological importance in
functional dyspepsia?.
Baillieres Clin
Gastroenterol.
1998;
12
557-571
MissingFormLabel
- 104
Haug T T, Svebak S, Wilhelmsen I, Berstad A, Ursin H.
Psychological factors and somatic symptoms in functional
dyspepsia. A comparison with duodenal ulcer and healthy
controls.
J Psychosom
Res.
1994;
38
281-291
MissingFormLabel
- 105
Platz T, Schepank H, Junkert B, Tress W.
Is there a typical conflict in dyspepsia? An epidemiologic
psychoanalytic contribution to the topic of a specific conflict in
psychosomatic medicine.
Psychother Psychosom Med
Psychol.
1993;
43
207-213
MissingFormLabel
- 106
Herschbach P, Henrich G, von
Rad M.
Psychological factors in functional gastrointestinal
disorders: Characteristics of the disorder or of the illness
behavior?.
Psychosom
Med.
1999;
61
148-153
MissingFormLabel
- 107
Rothenbacher D, Peter R, Bode G, Adler G, Brenner H.
Dyspepsia in relation to Helicobacter pylori infection and
psychosocial work stress in white collar employees.
Am J
Gastroenterol.
1998;
93
1443-1449
MissingFormLabel
- 108
Bennett E J, Piesse C, Palmer K. et al .
Functional gastrointestinal disorders: psychological, social,
and somatic
features.
Gut.
1998;
42
414-420
MissingFormLabel
- 109
Haug T T, Wilhelmsen I, Svebak S, Berstad A, Ursin H.
Psychotherapy in functional dyspepsia.
J Psychosom
Res.
1994;
38
735-744
MissingFormLabel
- 110
Mine K, Kanazawa F, Hosoi M, Kinukawa N, Kubo C.
Treating nonulcer dyspepsia considering both functional
disorders of the digestive system and psychiatric conditions.
Dig Dis
Sci.
1998;
43
1241-1247
MissingFormLabel
- 111
Bundesärztekammer, Kassenärztliche
Bundesvereinigung .
Beurteilungskriterien für Leitlinien in der
medizinischen Versorgung.
Dtsch
Ärztebl.
1997;
94
A2154
MissingFormLabel
- 112 US Department of Health and Human Services Public Health
Service & Agency for Health Care poliyc and Research .Using Clinical Practice Guidelines to Evaluate Quality of
Care. AHCPR 1995 Pub No.
95 - 0046
MissingFormLabel
- 113
Fullerton S, Mayer E A.
International Economic Impact of Functional Gastrointestinal
Disorders.
Gastrenterology.
1998;
114
A2487
MissingFormLabel
- 114 Delaney B C, Innes M A, Deeks J. et al .Initial Management Strategies for Dyspepsia (Cochrane
Review). The Cochrane
Library Oxford; Update
Software 2000 4
MissingFormLabel
- 115
Ofman J J, Rabeneck L.
The Effectiveness of Endoscopy in the Management of
Dyspepsia: A Qualitative Systematic Review.
Am J
Med.
1999;
106
335
MissingFormLabel
- 116
Fendrick A M, Chernew M E, Hirth R A, Bloom B S.
Alternative Management Strategies for Patients with Suspected
Peptic Ulcer Disease.
Ann Intern
Med.
1995;
123
260
MissingFormLabel
- 117
Birkner B, Fritz N.
Testen und Behandeln („Test and Treat”): Eine
gültige Empfehlung für das Management bei
Dyspepsie.
Gesundh Ökon Qual
Manag.
1999;
4
106
MissingFormLabel
- 118
Duggan A E, Elliott C, Logan R FA.
Testing for Helicobacter Pylori Infection: Validation and
diagnostic yield of a near patient test in primary
care.
BMJ.
1999;
319
1236-1239
MissingFormLabel
- 119
Heaney A, Collins J SA, Watson R GP. et al .
A Prospective Randomised Trial of a Test and Treat Policy
Versus Endoscopy Based Management in Young Helicobacter Pylori Positive
Patients with Ulcer-Like Dyspepsia, Referred to A Hospital
Clinic.
Gut.
1999;
45
186
MissingFormLabel
- 120
Joosen E A, Reininga J H, Manders J M, ten
Ham J C, de Boer W A.
Costs and Benefits of a Test and Treat Strategy in
Helicobacter Pylori Infected Subjects: A Prospective Intervention Study in
General Practice.
Eur J Gastroenterol
Hepatol.
2000;
12
319
MissingFormLabel
- 121
Duggan A, Elliot C, Tolley K. et al .
Randomised Controlled Trial of Four Dyspepsia Management
Strategies in Primary Care with 12 Month
Follow-up.
Gastroenterology.
2000;
118
A438
MissingFormLabel
Anschrift für die Verfasser
Prof. Dr. med. Peter Malfertheiner
Otto-von-Guericke Universität Magdeburg
Klinik
für Gastroenterologie, Hepatologie und
Infektiologie
Leipziger Straße 44
39120 Magdeburg
Email: peter.malfertheiner@medizin.uni-magdeburg.de